JP Morgan analyst Robbie Marcus downgrades Bioventus (NASDAQ:BVS) from Overweight to Underweight.
Zedge Board of Directors Authorized 1.5M Share Repurchase Program
Zedge, Inc. (NYSE AMERICAN: ZDGE), a leader in building marketplaces and games around digital content that enable self-expression, today announced that its Board of Directors authorized a share repurchase program permitting the Company to purchase up to an aggregate of 1.5 million shares of Class B common stock.
